US Patent Issued to NINEBIOPHARM on Feb. 17 for "Composition comprising Regentide-012 or Regentide-013 for improving skin condition" (South Korean Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,835, issued on Feb. 17, was assigned to NINEBIOPHARM Co. LTD. (Cheongji-si, South Korea).

"Composition comprising Regentide-012 or Regentide-013 for improving skin condition" was invented by Jae Hwan Kim (Sejong-si, South Korea), Ji Heon Rhim (Sejong-si, South Korea), Ri Ra Lee (Gwangju-si, South Korea), Hye In Ahn (Cheongju-si, South Korea), Hae Yeong Kang (Cheongju-si, South Korea) and Ga Hyun Kim (Suwon-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to Regentide-012 and Regentide-013 and, more specifically, to a use of Regentide-012 and Regentide-013 for improving skin conditions. Regentide-012 and Re...